Breast cancer cell

Breast cancer cells are malignant cells that originate in the mammary epithelial tissue, characterized by genomic instability and the loss of normal cell cycle control (NIH, 2023). These cells exhibit hallmarks of cancer such as sustained proliferative signaling, evasion of growth suppressors, and resistance to cell death (PubMed, 2022). While "breast cancer cells" are the focus of oncology, they do not represent a single molecular target; instead, they are a heterogeneous population defined by the expression of specific proteins like the Estrogen Receptor (ER) or Human Epidermal Growth Factor Receptor 2 (HER2) (American Cancer Society, 2024). Therapeutic strategies involve targeting these specific molecular drivers or using cytotoxic agents to disrupt cellular processes like mitosis (StatPearls, 2023). Consequently, the term refers to a disease state or biological entity rather than a specific therapeutic molecule (PubChem, 2024).

Other names

Malignant mammary epithelial cellBreast carcinoma cellMammary tumor cellBCC

Drugs targeting breast cancer cells function by inhibiting specific intracellular signaling pathways (e.g., HER2 or CDK4/6 inhibition), blocking hormonal stimulation of nuclear receptors (e.g., ER antagonism), or inducing direct DNA damage and mitotic arrest to trigger apoptosis (PubMed, 2022).